Medical Transcription Billing (NASDAQ:MTBC) Trading 6.4% Higher

Share on StockTwits

Medical Transcription Billing Corp (NASDAQ:MTBC) shares traded up 6.4% during mid-day trading on Wednesday . The company traded as high as $4.19 and last traded at $3.80, 222,000 shares changed hands during trading. An increase of 346% from the average session volume of 49,753 shares. The stock had previously closed at $3.57.

A number of equities research analysts have issued reports on the stock. National Securities assumed coverage on shares of Medical Transcription Billing in a report on Thursday, October 10th. They set a “buy” rating and a $6.00 price objective for the company. HC Wainwright reaffirmed a “buy” rating and set a $6.00 price objective on shares of Medical Transcription Billing in a report on Tuesday, October 15th.

The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.27 and a current ratio of 2.31. The business’s fifty day simple moving average is $3.87 and its 200-day simple moving average is $4.53. The firm has a market capitalization of $44.72 million, a PE ratio of -6.44 and a beta of 1.71.

Medical Transcription Billing (NASDAQ:MTBC) last announced its quarterly earnings data on Wednesday, November 6th. The technology company reported ($0.14) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.14). Medical Transcription Billing had a negative net margin of 5.01% and a negative return on equity of 8.85%. The business had revenue of $16.85 million during the quarter, compared to analyst estimates of $16.06 million. Sell-side analysts expect that Medical Transcription Billing Corp will post -0.55 earnings per share for the current fiscal year.

In related news, Director John N. Daly sold 8,000 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $4.63, for a total value of $37,040.00. Following the completion of the transaction, the director now directly owns 124,900 shares of the company’s stock, valued at $578,287. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John N. Daly sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $3.57, for a total transaction of $35,700.00. Following the completion of the transaction, the director now directly owns 106,900 shares of the company’s stock, valued at $381,633. The disclosure for this sale can be found here. Over the last three months, insiders sold 23,000 shares of company stock valued at $92,206. 50.50% of the stock is currently owned by insiders.

About Medical Transcription Billing (NASDAQ:MTBC)

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Featured Story: What are the disadvantages of after-hours trading?

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.